Every two minutes, a man is diagnosed with prostate cancer in our country. This disease is currently the second-leading cancer-related killer of men in the United States.

Prostate cancer is now the most common in England, new research has found. This week, charity Prostate Cancer UK said diagnoses of the disease had overtaken breast cancer in 2022 and 2023, making it ...

Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...

The Vermont Department of Health is investigating an outbreak of Legionnaire’s disease at a long-term care facility in Windsor, which has infected at least six people and claimed the life of one. The ...

Despite advances in conventional treatment modalities, patients with metastatic CRC often face limited options and poor outcomes. Chimeric antigen receptor-T (CAR-T) cell therapy, initially successful ...

These cells induce the expression of MHC II molecules and possess a limited capacity for antigen presentation. The non-professional APCs found in the lung include AECs, ECs, fibroblasts, ILCs, ...

Besides part of the virus they are designed to combat ... In this case, for example, we can simply remove the antigen [a piece of the SARS-CoV-2 spike protein] and replace it with a protein ...

Department of Pathology, UMass Chan Medical School, Worcester, Massachusetts.

Prostate-specific membrane antigen–positron emission tomography (PSMA-PET) detected metastatic disease in 46% of patients with high-risk prostate cancer previously classified as nonmetastatic by ...

Leveraging their unique structural attributes and facile modification capabilities, VLPs can serve as an effective platform for the delivery of tumor antigens, thereby stimulating the immune system ...